ChemicalBook > CAS DataBase List > Cefotaxime Impurity F

Cefotaxime Impurity F

Cefotaxime Impurity F Structure
Cefotaxime Impurity F
  • CAS No.175032-97-0
  • Chemical Name:Cefotaxime Impurity F
  • CBNumber:CB33154826
  • Molecular Formula:C30H30N10O12S4
  • Formula Weight:850.88
  • MOL File:175032-97-0.mol
Cefotaxime Impurity F Property
  • Density 1.91±0.1 g/cm3(Predicted)
  • pka 2.66±0.50(Predicted)
  • FDA UNII G54TSK1689
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal word
  • Hazard statements
  • Precautionary statements
Cefotaxime Impurity F Preparation Products And Raw materials
Raw materials
Preparation Products
Cefotaxime Impurity F Suppliers
Global(50)Suppliers
  • Supplier:
    Standardpharm Co. Ltd.
  • Tel:86-714-3992388
  • Email:overseasales1@yongstandards.com
  • Country:United States
  • ProdList:14332
  • Advantage:58
  • Supplier:
    Moxin Chemicals
  • Tel: +8617320513646
  • Email:Anna@molcoo.com
  • Country:China
  • ProdList:9434
  • Advantage:58
  • Supplier: Guangzhou PI PI Biotech Inc
  • Tel:020-81716320<br/>+86-13602409664
  • Email:Sales@pipitech.com
  • Country:China
  • ProdList:3633
  • Advantage:55
  • Supplier: ChemStrong Scientific Co.,Ltd
  • Tel:0755-0755-66853366<br/>13670046396
  • Email:sales@chem-strong.com
  • Country:China
  • ProdList:18131
  • Advantage:56
Cefotaxime Impurity F Spectrum
175032-97-0, Cefotaxime Impurity FRelated Search:
  • 原料药
  • 化学试剂
  • 头孢噻肟钠杂质
  • 杂质对照品
  • 头孢噻肟钠杂质优势供应
  • 头孢噻肟
  • C30H30N10O12S4
  • 头孢噻肟 EP 杂质 F(头孢噻肟二聚体)
  • 头孢噻肟酸杂质6(头孢噻肟酸EP杂质F)
  • (6R,7R)-3-(乙酰氧基甲基)-7-((Z)-2-(2-((((6R,7R)-7-((Z)-2-(2-氨基噻唑-4-基)) )-2-(甲氧基亚氨基)乙酰氨基)-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基)甲基)氨基)噻唑-4-基) -2-(甲氧基亚氨基)乙酰氨基)-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸 (头孢噻肟杂质)
  • 头孢噻肟杂质FCEFOTAXIMESODIUM-IMPURITYF(EP/BP)
  • 头孢噻肟二聚物
  • 头孢噻肟钠有关杂质F
  • 头孢噻肟钠EP杂质F
  • 头孢噻肟二聚体
  • 头孢噻肟钠杂质F
  • 头孢噻肟EP杂质F
  • 头孢噻肟开环甲酯二聚体(头孢噻肟二聚体)
  • 175032-97-0
  • CefotaximeSodium-ImpurityF(EP/BP)
  • Cefotaxime Sodium Impurity F
  • Cefotaxime EP Impurity F (Cefotaxime Dimer)
  • (6R,7R)-3-(Acetoxymethyl)-7-((Z)-2-(2-((((6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)amino)thiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (Cefotaxime Impurity)
  • Cefotaxime Impurity F (EP)
  • (6R,7R)-3-(acetoxymethyl)-7-((Z)-2-(2-((((6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)amino)thiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cefotaxime Dimer
  • Cefotaxime EP Impurity F
  • Cefotaxime Imp.F
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-[2-[[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]amino]-4-thiazolyl](methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)- (9CI)
  • Cefotaxime Dimer A
  • Cefotaxime Dimer DISCONTINUED